Extracorporeal assays of thrombosis

Methods in Molecular Biology

Volumn 788, Issue , 2012, Pages 43-57

  Badimon, Lina ^a,b   Padro, Teresa ^a,b   Vilahur, Gemma ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Atherothrombosis; Pig animal model of thrombosis; Platelets

Indexed keywords

ANIMAL; ARTICLE; BIOASSAY; BIOREACTOR; DIFFUSION CHAMBER; DISEASE MODEL; EXTRACORPOREAL CIRCULATION; METHODOLOGY; PATHOPHYSIOLOGY; RABBIT; SWINE; THROMBOSIS;

ANIMALS; BIOLOGICAL ASSAY; BIOREACTORS; DIFFUSION CHAMBERS, CULTURE; DISEASE MODELS, ANIMAL; EXTRACORPOREAL CIRCULATION; RABBITS; SWINE; THROMBOSIS;

ANIMALIA; SUIDAE;

EID: 84555188439     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-307-3_4     Document Type: Article

References (34)

1. Badimon L, Vilahur G, Padro T. (2009) Lipoproteins, platelets and atherothrombosis. Rev Esp Cardiol. 62 , 1161-1178.
2. Badimon L, Badimon JJ, Vilahur G, et al. (2002) Pathogenesis of the acute coronary syndromes and therapeutic implications. Pathophysiol Haemost Thromb. 32 , 225-231. (Pubitemid 37490543)
3. Sakariassen KS, Aarts PA, de Groot PG, et al. (1983) A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med. 102 , 522-535. (Pubitemid 13013856)
4. Baumgartner HR. (1973) The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. Microvasc Res. 5 , 167-179.
5. Martines E, McGhee K, Wilkinson C, et al. (2004) A parallel-plate flow chamber to study initial cell adhesion on a nanofeatured surface. IEEE Trans Nanobioscience. 3 , 90-95.
6. Badimon L, Turitto V, Rosemark JA, et al. (1987) Characterization of a tubular flow chamber for studying platelet interaction with biologic and prosthetic materials: deposition of indium 111-labeled platelets on collagen, subendothelium, and expanded polytetrafluoroethylene. J Lab Clin Med. 110 , 706-718. (Pubitemid 18033264)
7. Badimon L, Badimon JJ, Turitto VT, et al. (1990) Platelet interaction to prosthetic materials-role of von Willebrand factor in platelet interaction to PTFE. J Biomater Appl. 5 , 27-48. (Pubitemid 23575240)
8. Badimon L, Badimon JJ, Turitto VT, et al. (1987) Role of von Willebrand factor in platelet interaction with an expanded PTFE surface. ASAIO Trans. 33 , 621-625.
9. Badimon L, Badimon JJ. (1989) Mechanisms of arterial thrombosis in nonparallel streamlines: platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in the pig model. J Clin Invest. 84 , 1134-1144. (Pubitemid 19247583)
10. Badimon L, Badimon JJ, Turitto VT, et al. (1987) Thrombosis: studies under flow conditions. Ann N Y Acad Sci. 516 , 527-540.
11. Badimon L, Badimon JJ, Rand J, et al. (1987) Platelet deposition on von Willebrand factordeficient vessels. Extracorporeal perfusion studies in swine with von Willebrand's disease using native and heparinized blood. J Lab Clin Med. 110 , 634-647. (Pubitemid 18033256)
12. Fuster V, Ip JH, Badimon L, et al. (1991) Importance of experimental models for the development of clinical trials on thromboatherosclerosis. Circulation. 83 , IV15-25.
13. Badimon L, Badimon JJ, Galvez A, et al. (1986) Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model. Arteriosclerosis. 6 , 312-320. (Pubitemid 16077316)
14. Mailhac A, Badimon JJ, Fallon JT, et al. (1994) Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets. Circulation. 90 , 988-996.
15. Toschi V, Gallo R, Lettino M, et al. (1997) Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 95 , 594-599. (Pubitemid 27063034)
16. Badimon JJ, Lettino M, Toschi V, et al. (1999) Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation. 99 , 1780-1787. (Pubitemid 29181404)
17. Vilahur G, Duran X, Juan-Babot O, et al. (2004) Antithrombotic effects of saratin on human atherosclerotic plaques. Thromb Haemost. 92 , 191-200. (Pubitemid 39010883)
18. Zafar MU, Vilahur G, Choi BG, et al. (2007) A novel anti-ischemic nitric oxide donor (LA419) reduces thrombogenesis in healthy human subjects. J Thromb Haemost. 5 , 1195-1200. (Pubitemid 46902122)
19. Chelliah R, Lucking AJ, Tattersall L, et al. (2009) P-selectin antagonism reduces thrombus formation in humans. J Thromb Haemost. 7 , 1915-1919.
20. Sarich TC, Osende JI, Eriksson UG, et al. (2003) Acute antithrombotic effects of ximelagatran, an oral direct thrombin inhibitor, and r-hirudin in a human ex vivo model of arterial thrombosis. J Thromb Haemost. 1 , 999-1004.
21. Zafar MU, Vorchheimer DA, Gaztanaga J, et al. (2007) Antithrombotic effects of factor Xa inhibition with DU-176b: Phase-I study of an oral, direct factor Xa inhibitor using an exvivo flow chamber. Thromb Haemost. 98 , 883-888. (Pubitemid 47555083)
22. Dangas G, Badimon JJ, Coller BS, et al. (1998) Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab. Arterioscler Thromb Vasc Biol. 18 , 1342-1349. (Pubitemid 28376193)
23. Dewanjee MK, Rao SA, Didisheim P. (1981) Indium-111 tropolone, a new high-affinity platelet label: preparation and evaluation of labeling parameters. J Nucl Med. 22 , 981-987. (Pubitemid 12233634)
24. Alfon J, Pueyo Palazon C, Royo T, et al. (1999) Effects of statins in thrombosis and aortic lesion development in a dyslipemic rabbit model. Thromb Haemost. 81 , 822-827. (Pubitemid 29216572)
25. Badimon L, Fuster V, Chesebro JH, et al. (1983) New "ex vivo" radioisotopic method of quantitation of platelet deposition-studies in four animal species. Thromb Haemost. 50 , 639-644. (Pubitemid 14241249)
26. Badimon L, Badimon JJ, Turitto VT, et al. (1989) Role of von Willebrand factor in mediating platelet-vessel wall interaction at low shear rate; the importance of perfusion conditions. Blood. 73 , 961-967. (Pubitemid 19078374)
27. Badimon JJ, Weng D, Chesebro JH, et al. (1994) Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity. Thromb Haemost. 71 , 511-516. (Pubitemid 24100680)
28. Vilahur G, Segales E, Salas E, et al. (2004) Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow-and lesion-dependent thrombosis in the porcine ex vivo model. Circulation. 110 , 1686-1693. (Pubitemid 39297994)
29. Vilahur G, Baldellou MI, Segales E, et al. (2004) Inhibition of thrombosis by a novel platelet selective S-nitrosothiol compound without hemodynamic side effects. Cardiovasc Res. 61 , 806-816. (Pubitemid 38249480)
30. Vilahur G, Casani L, Badimon L. (2007) A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis. Thromb Haemost. 98 , 662-669. (Pubitemid 47412894)
31. Vilahur G, Pena E, Padro T, et al. (2007) Protein disulphide isomerase-mediated LA419-NO release provides additional antithrombotic effects to the blockade of the ADP receptor. Thromb Haemost. 97 , 650-657. (Pubitemid 46603437)
32. Lev EI, Hasdai D, Scapa E, et al. (2004) Administration of eptifibatide to acute coronary syndrome patients receiving enoxaparin or unfractionated heparin: effect on platelet function and thrombus formation. J Am Coll Cardiol. 43 , 966-971. (Pubitemid 38352973)
33. Badimon JJ, Badimon L, Turitto VT, et al. (1991) Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels. In vivo study in the rabbit model. Arterioscler Thromb. 11 , 395-402.
34. Osende JI, Badimon JJ, Fuster V, et al. (2001) Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control. J Am Coll Cardiol. 38 , 1307-1312. (Pubitemid 33033003)